|1.||Ross, R Paul: 5 articles (01/2015 - 03/2004)|
|2.||Kuipers, Oscar P: 5 articles (01/2015 - 03/2007)|
|3.||Hill, Colin: 5 articles (01/2015 - 03/2004)|
|4.||Moll, Gert N: 5 articles (01/2015 - 03/2007)|
|5.||Cotter, Paul D: 4 articles (01/2015 - 07/2010)|
|6.||Field, Des: 4 articles (01/2015 - 07/2010)|
|7.||Kluskens, Leon D: 4 articles (11/2008 - 03/2007)|
|8.||Rishi, Praveen: 3 articles (11/2015 - 01/2013)|
|9.||Lubelski, Jacek: 3 articles (01/2015 - 08/2008)|
|10.||O'Connor, Paula M: 3 articles (01/2015 - 07/2010)|
04/01/2012 - "MTAD in combination with nisin improved antibacterial efficacy against pathogens, especially for some gram-positive bacteria associated with persistent intracanal infection. "
04/01/2012 - "The object of this study was to evaluate the effect of MTAD in combination with nisin on the pathogens associated with root canal infection. "
08/01/2013 - "Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice."
04/01/2012 - "In vitro evaluation of MTAD and nisin in combination against common pathogens associated with root canal infection."
12/01/2010 - "To determine the ability of nisin F to control systematic infection caused by Staphylococcus aureus, using C57BL/6 mice as a model. "
08/01/2008 - "The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation."
08/01/2007 - "Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows."
08/01/2008 - "No clinical signs of mastitis were observed among the women of the nisin group on day 14, whereas they persisted throughout the study in the women of the control group. "
09/01/2007 - "Because of its therapeutic effects on bovine subclinical mastitis, as well as its safety in humans, nisin deserves further study to clarify its effects on mastitis caused by different pathogens."
09/01/2007 - "The objectives of this study were to evaluate an antimicrobial peptide, nisin, in the treatment of subclinical mastitis in lactating cows. "
|3.||Acquired Immunodeficiency Syndrome (AIDS)
05/31/1996 - "Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) of isolated CE fractions provides molecular mass information that aids in identification of the nisin degradants and determination of peak purity. "
09/01/2009 - "This unique property of nisin can be exploited in the development of a safe and effective vaginal microbicide for the prevention of sexually transmitted infections/acquired immunodeficiency syndrome (STIs/AIDS) and unplanned pregnancies."
|4.||Body Weight (Weight, Body)
12/01/2012 - "Our studies are the first to report CHAC1's new role in promoting cancer cell apoptosis under nisin treatment. "
01/01/2015 - "Nisin exemplifies this new approach because it has been used safely in humans for many years as a food preservative, and recent laboratory studies support its anti-tumor potential in head and neck cancer. "
11/01/2015 - "These results point towards the possible use of nisin as an adjunct to doxorubicin may help in developing alternate strategies to combat currently developing drug resistance in cancer cells. "
01/01/2015 - "The use of small antimicrobial peptides or bacteriocins, like nisin, to treat cancer is a new approach that holds great promise. "
11/01/1992 - "Proteins of this subfamily are responsible for the secretion of a variety of compounds, including large polypeptides, polysaccharides, and anti-drug tumors, indicating that NisT may be involved in nisin transport. "
|1.||Anti-Bacterial Agents (Antibiotics)
|3.||RNAIII inhibiting peptide
|6.||Polymyxin B (Aerosporin)
|7.||Ethylene Oxide (Oxirane)
|3.||Drug Therapy (Chemotherapy)